0001179110-19-009747.txt : 20190821
0001179110-19-009747.hdr.sgml : 20190821
20190821161803
ACCESSION NUMBER: 0001179110-19-009747
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190819
FILED AS OF DATE: 20190821
DATE AS OF CHANGE: 20190821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haviland Kate
CENTRAL INDEX KEY: 0001663022
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37359
FILM NUMBER: 191043275
MAIL ADDRESS:
STREET 1: BLUEPRINT MEDICINES CORPORATION
STREET 2: 38 SIDNEY STREET, SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2019-08-19
0
0001597264
Blueprint Medicines Corp
BPMC
0001663022
Haviland Kate
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Operating Officer
Common Stock
2019-08-19
4
M
0
95
16.28
A
15960
D
Common Stock
2019-08-19
4
S
0
95
85.00
D
15865
D
Stock Option (Right to Buy)
16.28
2019-08-19
4
M
0
95
0
D
2026-02-01
Common Stock
95
15552
D
Effected pursuant to a trading plan adopted on April 19, 2019 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
This option was granted on February 1, 2016. This option vested with respect to 25% of the shares underlying the option on January 5, 2017 and as to an additional 1/48th of the shares underlying the option each month thereafter.
/s/ Christopher Frankenfield, Attorney-in-Fact
2019-08-21